alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
I 

115TH CONGRESS 

2D SESSION H. R. 5777 

To direct the Secretary of Health and Human Services to make available 

on the Centers for Medicare & Medicaid Services website opioid prescribing guidance applicable to individuals entitled to benefits under 

part A or enrolled under part B of the Medicare program and update 

such guidance periodically. 

IN THE HOUSE OF REPRESENTATIVES 

MAY 11, 2018 

Mr. BUCHANAN (for himself and Mr. LAMB) introduced the following bill; 

which was referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of 

such provisions as fall within the jurisdiction of the committee concerned 

A BILL 

To direct the Secretary of Health and Human Services to 

make available on the Centers for Medicare & Medicaid 

Services website opioid prescribing guidance applicable 

to individuals entitled to benefits under part A or enrolled under part B of the Medicare program and update 

such guidance periodically. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


pbinns on DSK79D2C42PROD with BILLS
2 

•HR 5777 IH

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘Centralized Opioid 

3 Guidance Act of 2018’’ or the ‘‘COG Act of 2018’’. 

4 SEC. 2. REQUIRING THE POSTING AND ANNUAL UPDATING 

5 OF OPIOID PRESCRIBING GUIDANCE FOR 

6 MEDICARE BENEFICIARIES. 

7 (a) IN GENERAL.—Not later than 180 days after the 

8 date of the enactment of this Act, the Secretary of Health 

9 and Human Services (in this section referred to as the 

10 ‘‘Secretary’’) shall post on the public website of the Cen11 ters for Medicare & Medicaid Services all guidance pub12 lished by the Department of Health and Human Services 

13 on or after January 1, 2016, relating to the prescribing 

14 of opioids and applicable to opioid prescriptions for indi15 viduals entitled to benefits under part A of title XVIII 

16 of the Social Security Act (42 U.S.C. 1395c et seq.) or 

17 enrolled under part B of such title of such Act (42 U.S.C. 

18 1395j et seq.). 

19 (b) UPDATE OF GUIDANCE.— 

20 (1) PERIODIC UPDATE.—The Secretary shall, in 

21 consultation with the entities specified in paragraph 

22 (2), periodically (as determined appropriate by the 

23 Secretary) update guidance described in subsection 

24 (a) and revise the posting of such guidance on the 

25 website described in such subsection. 


pbinns on DSK79D2C42PROD with BILLS
3 

•HR 5777 IH

1 (2) CONSULTATION.—The entities specified in 

2 this paragraph are the following: 

3 (A) Medical professional organizations. 

4 (B) Providers and suppliers of services (as 

5 such terms are defined in section 1861 of the 

6 Social Security Act (42 U.S.C. 1395x)). 

7 (C) Health care consumers or groups rep8 resenting such consumers. 

9 (D) Other entities determined appropriate 

10 by the Secretary. 

Æ 


pbinns on DSK79D2C42PROD with BILLS
**UN PUBLISHED** 
UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT

**No. 1**  **4 -**  **7349**

UNITED STATES OF AMERICA , Plaintiff

- Appellee ,
v. JAWAAD NASH, a/k/a Wad , Defendant

- Appellant
.

Appeal from the United States District Court for the Western District of North Carolina , at Charlotte
. Frank D. Whitney , Chief District Judge. ( 3:09

- cr - 00039

- FDW

- 2; 3:12

- cv - 00283

- FDW )

Submitted : January 15, 2015 Decided: January 2 3 , 2015

Before GREGORY and AGEE , Circuit Judges, and HAMILTON, Senior Circuit Judge.

Dismissed by un published per curiam opinion
. Jawaad Nash, Appellant Pro Se. William A. Brafford, Kelli Hamby Ferry, Assistant United States Attorneys, Charlotte, North Carolina; Amy Elizabeth Ray, Assistant United States Attorney, As heville, North Carolina, for Appellee.
Unpublished opinions are not binding precedent in this circuit.2 PER CURIAM: Jawaad Nash seeks to appeal the district court’s order treating his Fed. R. Civ. P. 60(b) motion as a successive 28 U.S.C. § 2255 ( 2012 ) motion, and dismissing it on that basis. The order is not appealable unless a circuit justice or judge issues a certificate of appealability. 28 U.S.C.
§ 2253(c)(1) (B) (2012) . A certificate of appealability will not issue absent “a substantial showing of the denial of a constitutional right.” 28 U.S.C. § 2253(c)(2) (2012)
. When the district court denies relief on the merits, a prisoner satisfies this standard by demonstrating that reasonable jurists would find that the district court’s assessment of the constitutional claims is debatable or wrong. Slack v. McDaniel , 529 U.S. 473, 484 (2000); see Miller

- El v. Cockrell , 537 U.S. 322, 336

- 38 (2003). When the district court denies relief on procedural grounds, the prisoner must demonstrate both that the dispositive procedural ruling is debatable, and that the motion states a debatable claim of the denial of a constitutional right. Slack , 529 U.S. at 484

- 85. We have independently reviewed the record and conclude that Nash has not made the requisite sho wing. Accordingly, we deny a certificate of appealability and dismiss the appeal.3 Additionally, we construe Nash’s notice of appeal and informal brief as an application to file a second or successive
§ 2255 motion. United States v. Winestock , 340 F.3d 200, 208 (4th Cir. 2003). In order to obtain authorization to file a successive § 2255 motion, a prisoner must assert claims based on either: (1) newly discovered evidence that
. . . would be sufficient to establish by clear and convincing evidence that n o reasonable factfinder would have found the movant guilty of the offense; or (2) a new rule of constitutional law, made retroactive to cases on collateral review by the Supreme Court , that was previously unavailable
. 28 U.S.C. § 22 55(h ) (2012)
. Nash’s claims do not satisfy either of these criteria. Therefore, we deny authorization to fi le a successive § 2255 motion. We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before th is court and arg ument would not aid the decisional
process. DISMISSED
Report of Independent Auditors

To the Trustees and Beneficial Shareholders
DMC Tax-Free Income Trust - Pennsylvania

In planning and performing our audit of the financial statements
of DMC Tax-Free Income Trust - Pennsylvania (the "Trust") for the
year ended February 28, 1997, we considered its internal control
structure, including procedures for safeguarding securities, in
order to determine our auditing procedures for the purpose of
expressing our opinion on the financial statements and to comply
with the requirements of Form N-SAR, not to provide assurance on
the internal control structure.

The management of the Trust is responsible for establishing and
maintaining an internal control structure. In fulfilling this
responsibility, estimates and judgments by management are
required to assess the expected benefits and related costs of
internal control structure policies and procedures. Two of the
objectives of an internal control structure are to provide
management with reasonable, but not absolute, assurance that
assets are safeguarded against loss from unauthorized use or
disposition and that transactions are executed in accordance with
management's authorization and recorded properly to permit
preparation of financial statements in conformity with generally
accepted accounting principles.

Because of inherent limitations in any internal control
structure, errors or irregularities may occur and not be
detected. Also, projection of any evaluation of the structure to
future periods is subject to the risk that it may become
inadequate because of changes in conditions or that the
effectiveness of the design and operation may deteriorate.

Our consideration of the internal control structure would not
necessarily disclose all matters in the internal control
structure that might be material weaknesses under standards
established by the American Institute of Certified Public
Accountants. A material weakness is a condition in which the
design or operation of the specific internal control structure
elements does not reduce to a relatively low level the risk that
errors or irregularities in amounts that would be material in
relation to the financial statements being audited may occur and
not be detected within a timely period by employees in the normal
course of performing their assigned functions. However, we noted
no matters involving the internal control structure, including
procedures for safeguarding securities, that we consider to be
material weaknesses as defined above as of February 28, 1997.

This report is intended solely for the information and use of
management and the Securities and Exchange Commission.



April 4, 1997
AGENDA

Advisory Board on Radiation and Worker Health 

Meeting of the

Pinellas Work Group

October 13, 2011

Cincinnati Airport Marriott 

2395 Progress Dr. 

Hebron, KY 41048 

859-586-0166

Conference Call Number: 1-866-659-0537

Participant Pass Code: 9933701

9:00 a.m. Eastern Time Welcome and roll-call/introductions 

Work Group Discussion 

• NIOSH Summary of revised Site Description TBD

• WG and S&A Comments and Questions 

• NIOSH Summary of revised External Dose TBD

• WG and S&A Comments and Questions 

• NIOSH Summary of revised Internal Dose TBD

• WG and S&A Comments and Questions 

• NIOSH Summary of revised Environmental Dose TBD 

• WG and S&A Comments and Questions 

• NIOSH Summary of Medical Dose TBD (in revision) 

• WG and S&A Comments and Questions 

• Action Items/Plans

Adjourn
#### SECURITY BARGE LINE, INC., a corporation, Plaintiff-Appellant, v. Maria Graciela McCRAY, Administratrix of the Estate of James Manly McCray, Deceased, Defendant-Appellee.

No. 77-2543

Summary Calendar.*

United States Court of Appeals, Fifth Circuit.

Oct. 11, 1978.

*14Philip Mansour, Stephen L. Thomas, Greenville, Miss., Hubert I. Binowitz, St. Louis, Mo., for plaintiff-appellant.

Howard Dyer, III, Prank S. Thackston, Jr., Greenville, Miss., for defendant-appellee.

Before BROWN, Chief Judge, COLEMAN and VANCE, Circuit Judges.

*

 Rule 18, 5 Cir.; *see Isbell Enterprises,*Inc. v. *Citizens Casualty Co. of New York et al., 5 Cir., 1970, 431 F.2d 409, Part I.*

PER CURIAM.

In this admiralty case, Security Barge Line, Inc. sued the estate of its seaman employee, James Manly McCray, for damages to its vessel, the M/V Washington, caused by an engine room fire. The barge line alleged that McCray, who was killed in the blaze, negligently caused the fire. McCray’s widow, as administratrix of his estate, counterclaimed against the barge line, claiming that the barge line’s negligence and the unseaworthiness of its vessel caused decedent’s death.

The district court found that the barge line failed to prove that McCray was negligent or that his acts had caused the fire. It concluded that although the cause of the fire was unknown decedent’s death resulted from the vessel’s unseaworthiness. Damages of $250,000.00 were awarded to McCray’s survivors.

On appeal, the barge line attacks the lower court’s findings specifically contending, (1) that the district court erred in its holding that the M/V Washington was unseaworthy; (2) that the district court erred in ignoring uncontradicted evidence of negligence on the part of the decedent McCray, and (3) that the district court erred in its assessment of damages.

In his memorandum opinion of July 8, 1977 Chief Judge Keady painstakingly considered each of these contentions. Based upon the findings of facts and conclusions of law as embodied in his opinion, we affirm the district court’s judgment.

■ AFFIRMED.
ARUN-EX 10.48-2014.7.31




Exhibit 10.48


CONFIDENTIAL TREATMENT REQUESTED
CONFIDENTIAL PORTIONS OF THIS DOCUMENT HAVE BEEN REDACTED AND HAVE BEEN SEPARATELY FILED WITH THE SECURITIES AND EXCHANGE COMMISSION
Amendment #6
to ScanSource, Inc,
Distribution Agreement
This Amendment #6 to the Distribution Agreement dated June 4, 2007 (the “Agreement”) and modified in Amendment #1 dated March 17, 2008, Amendment #2 dated May 27, 2009, Amendment #3 dated May 6, 2013, Amendment #4 dated November 1, 2013 and Amendment #5 dated January 21, 2014 is made and entered into as of June 1, 2014 (“Effective Date”) by and between Aruba Networks, Inc., having its principal place of business at 1344 Crossman Avenue, Sunnyvale, CA 94089 (“Aruba”), and ScanSource, Inc., with an address at 6 Logue Court, Greenville, South Carolina 29615 (“ScanSource”).  Capitalized terms used herein and not otherwise defined herein shall have the meaning ascribed to such terms in the Agreement.
WHEREAS, Aruba and ScanSource entered into a Distribution Agreement dated June 4, 2007; and
WHEREAS, Aruba and ScanSource now desire to amend the Agreement as set forth herein.
NOW, THEREFORE, in consideration of the mutual covenants and promises set forth herein, the parties hereby agree as follows:
A.    In Exhibit A of the Agreement, the Non-Standard Pricing (NSP) area within the Section entitled “PRODUCT & PRICE LIST” is hereby removed in its entirety and replaced with the following:
PRODUCT & SERVICES PRICING/DISCOUNTS
		
	•
	All Products: (Categories - MC, AP, IAP, MX, SW, HW, MR, MAS, CL, OT and ACC)


		
	◦
	Non-Standard Pricing (NSP) - For Product being sold to Resellers using non-standard pricing agreed to between Aruba and Reseller, unless otherwise negotiated between Aruba and Distributor, Aruba will offer Distributor a discount equivalent of list price above the non-standard pricing being offered to the Reseller such that Distributor will earn a [***] gross margin.


B.    This Amendment may be executed in counterparts, each of which shall be deemed to be an original, but all of which shall constitute one and the same agreement.
C.    Except as provided herein, all other terms and conditions of the Agreement shall remain in full force and effect.

*** Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission.  Confidential treatment has been requested with respect to the omitted portions.




IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed by their respective authorized representatives as of the Effective Date.
ARUBA NETWORKS, INC.        SCANSOURCE, INC.
By:     /s/ Ava Hahn        By:  /s/ Ansley Hoke    
Print Name: Ava Hahn        Print Name: Ansley Hoke    
Title: General Counsel        Title: VP Merchandising ScanSource Catalyst    
Date: June 2, 2014        Date: 5/30/14
EXHIBIT 31.01



Certification of Mindy Kline, Chief Executive Officer pursuant to

Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended.





I, Mindy Kline, certify that:



1.

I have reviewed this quarterly report on Form 10-Q of Gold Star Tutoring Services, Inc. for the quarterly period ended March 31, 2009;



2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;



3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;



4.

The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:



(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;



(b)

Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and



(c)

Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and



5.

The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):



(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and



(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.



April 30, 2009

___/s/Mindy Kline_____________

Mindy Kline

Chief Executive Officer

Principal Executive Officer
[Federal Register Volume 73, Number 23 (Monday, February 4, 2008)]
[Notices]
[Pages 6518-6519]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 08-467]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of General Medical Sciences; Notice of Closed 
Meetings

     Pursuant to section 120(d) of the Federal Advisory Committee Act, 
as amended (5 U.S.C. Appendix 2), notice is hereby given of the 
following meetings.
     The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material,

[[Page 6519]]

and personal information concerning individuals associated with the 
grant applications, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

    Name of Committee: National Institute of General Medical 
Sciences Special Emphasis Panel Minority Biomedical Research Support 
in Neurobiology and Physiology.
    Date: February 25-26, 2008.
    Time: 8:30 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Margaret J. Weidman, PhD, Office of Scientific 
Review, National Institute of General Medical Sciences, National 
Institutes of Health, 45 Center Drive, Room 3AN18B, Bethesda, MD 
20892, 301-594-3663, <a href="/cdn-cgi/l/email-protection#5c2b393538313d32313d1c32353b312f72323534723b332a"><span class="__cf_email__" data-cfemail="0374666a676e626d6e62436d6a646e702d6d6a6b2d646c75">[email protected]</span></a>.

    Name of Committee: National Institute of General Medical 
Sciences Special Emphasis Panel, Minority Biomedical Research 
Support in Genetics.
    Date: February 27-28, 2008.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: John J. Laffan, PhD, Office of Scientific 
Review, National Institute of General Medical Sciences, National 
Institutes of Health, Natcher Building, Room 3AN18J, Bethesda, MD 
20892, 301-594-2773.

(Catalogue of Federal Domestic Assistance Program Nos. 93.375, 
Minority Biomedical Research Support; 93.821, Cell Biology and 
Biophysics Research; 93.859, Pharmacology, Physiology, and 
Biological Chemistry Research; 93.862, Genetics and Developmental 
Biology Research; 93.88, Minority Access to Research Careers; 93.96, 
Special Minority Initiatives, National Institutes of Health, HHS)

    Dated: January 28, 2008.
Jennifer Spaeth,
Director of Federal Advisory Committee Policy.
[FR Doc. 08-467 Filed 2-1-08; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Exhibit 32.1
                                                           ------------


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350

In connection with the filing by Ametrine  Capital,  Inc. (the "Company") of the
Quarterly  Report on Form 10-Q for the quarter ended June 30, 2009 as filed with
the Securities  and Exchange  Commission on the date hereof (the  "Report"),  I,
Lior Ostashinsky,  President and Treasurer of the Company,  certify, pursuant to
18 U.S.C. 1350, that to my knowledge:

1.   The Report fully complies with the  requirements  of Section 13(a) or 15(d)
     of the Securities Exchange Act of 1934; and

2.   The information  contained in the Report fairly  presents,  in all material
     respects, the financial condition and results of operations of the Company.




Date: August 17, 2009             By: /s/ Lior Ostashinsky
                                          -----------------------
                                          Lior Ostashinsky
                                          President and Treasurer (Principal
                                          Executive and Financial Officer)